Latest Breaking News On - Bio pharma inc - Page 7 : comparemela.com

Rhumbline Advisers Raises Holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO)

Rhumbline Advisers grew its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 1.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 179,759 shares of the company’s stock after acquiring an additional 1,924 shares during the period. […]

Arizona
United-states
Bio-pharma
Frank-mccormick
Randalw-scott
Cantor-fitzgerald
Nasdaq
Envestnet-asset-management-inc
Bridgebio-pharma-inc
Bio-pharma-inc
Kokusai-asset-management-co
Exchange-commission

313,381 Shares in BridgeBio Pharma, Inc. (NASDAQ:BBIO) Purchased by Boone Capital Management LLC

313,381 Shares in BridgeBio Pharma, Inc. (NASDAQ:BBIO) Purchased by Boone Capital Management LLC
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China
Hannah-valantine
Bio-pharma
Bridgebio-pharma
Randalw-scott
Nasdaq
Bio-pharma-inc
Exchange-commission
China-universal-asset-management-co
Covestor-ltd
Bridgebio-pharma-inc
Securities-exchange-commission

Boone Capital Management LLC Makes New $8.26 Million Investment in BridgeBio Pharma, Inc. (NASDAQ:BBIO)

Boone Capital Management LLC Makes New $8.26 Million Investment in BridgeBio Pharma, Inc. (NASDAQ:BBIO)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Bridgebio-pharma
Randalw-scott
Bio-pharma
Hannah-valantine
Cantor-fitzgerald
Topco-ltd
Bridgebio-pharma-company-profile
Bridgebio-pharma-inc
Securities-exchange-commission
Wells-fargo-company
Boone-capital-management
Citigroup

BridgeBio Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update

- Submitted New Drug Application to US Food and Drug Administration for acoramidis for the treatment of transthyretin amyloid cardiomyopathy based on positive results of Phase 3 ATTRibute-CM trial,.

United-states
Ukraine
Australia
Israel
Gaza-strip
Japan
American
Japanese
Neil-kumar
Brian-stephenson
Vikram-bali
Drug-administration

BridgeBio Pharma Inc. (BBIO) Misses Q4 EPS by 9c

BridgeBio Pharma Inc. (BBIO) Misses Q4 EPS by 9c
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Bio-pharma-inc
Bridgebio-pharma-inc
Nasdaq
Bridgebio-pharma